Get the app
NSEHealthcare

Amrutanjan Health Care Limited (AMRUTANJAN)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹491.00+0.12%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
₹103 cr
Revenue YoY
+9.5%
Net profit
₹4 cr
Profit YoY
-47.5%
EPS
₹-0.48
EPS estimate
₹0.81
Net margin
4.2%

EPS came in at -0.48 against a street estimate of 0.81 — a miss of 159.3%.

Key statistics

Market cap
₹1,415 cr
P/E
26.2
Forward P/E
59.9
P/B
3.83
Book value
₹128.04
EPS (TTM)
₹18.66
52-week high
₹765.17
52-week low
₹479.96
50-day MA
₹517.45
200-day MA
₹565.79
Beta
0.38

Shareholding

Promoters
49.16%
Institutions
10.95%

Recent filings & reports

DocumentDate
Investor presentation · Q1 FY27
AMRUTANJAN HEALTH CARE LIMITED – Q1 FY27 SUMMARY HEADLINE NUMBERS • Net Sales: ₹102.97 crores (Q1 FY27) vs ₹94.05 crores (Q1 FY26) – Growth of 9.48%
2026-08-12
Quarterly results · Q1 FY27
AMRUTANJAN HEALTH CARE LIMITED – Q1 FY2026-27 SUMMARY --- HEADLINE NUMBERS • Q1 FY2026-27 Revenue from Operations: INR 10,296.88 lakhs (down 9.4% Y
2026-08-11
Quarterly results · Q4 FY26
AMRUTANJAN HEALTH CARE LIMITED – DOCUMENT SUMMARY HEADLINE NUMBERS • Full Year FY 2025-26 Revenue from Operations: Rs. 50,255.27 lakhs (up 11.2% fro
2026-05-13
Investor presentation · Q4 FY26
AMRUTANJAN HEALTH CARE LIMITED – INVESTOR SUMMARY Quarter & Year Ended 31st March 2026 --- HEADLINE NUMBERS • FY26 Net Sales: Rs 502.55 Cr (FY25: R
2026-05-09
Investor presentation
AMRUTANJAN HEALTH CARE LIMITED – INVESTOR SUMMARY Q3 & 9M FY2026 Performance (Period Ended December 31, 2025) --- HEADLINE NUMBERS • Q3 FY26 Net Sa
2026-02-04
Quarterly results · Q3 FY26
AMRUTANJAN HEALTH CARE LIMITED – FINANCIAL SUMMARY Q3 FY2025-26 (Quarter & 9-Month Results) --- HEADLINE NUMBERS • Q3 Revenue from Operations: INR
2026-02-03
Investor presentation · Q2 FY26
AMRUTANJAN HEALTH CARE LIMITED – INVESTOR SUMMARY Q2 & H1 FY26 (April-September 2025) --- HEADLINE NUMBERS • H1 FY26 Net Sales: Rs 211.75 Cr (up 9.
2025-11-11
Quarterly results · Q2 FY26
AMRUTANJAN HEALTH CARE LIMITED – Q2 FY2025-26 FINANCIAL SUMMARY HEADLINE NUMBERS • Q2 FY2025-26 Revenue from Operations: INR 11,770.02 lakhs (vs INR
2025-11-10

Readable in the app.

Corporate actions

ActionDetailDate
Dividend₹2.90 / share
ex-date Sep 11, 2026
2026-09-11
Dividend₹1 / share
ex-date Feb 6, 2026 · record Feb 7, 2026
2026-02-06
Dividend₹1 / share
ex-date Nov 18, 2025
2025-11-18
Dividend₹2.60 / share
ex-date Sep 16, 2025
2025-09-16

Deals & corporate news

AnnouncementDate
Special dividend of Re. 1 per equity share declared
Amrutanjan Health Care Limited's Board of Directors declared a special dividend of Re. 1 (one rupee) per equity share on November 10, 2025. What happened: The company announced an additiona
2025-11-10

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Amrutanjan Health Care Limited — free to start.

Google PlayApp Store

Other Healthcare companies

Data updated 2026-09-18.